Quzyttir Injection
Product Images NDC 68118-200

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quzyttir (NDC 68118-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esteve Pharmaceuticals, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68118-200-01_vial (68118 200 01 Vial)

68118-200-01_vial (68118 200 01 Vial)
Label for Quzyttir Cetirizine Hydrochloride Injection, 10 mg/mL, 1 mL single-dose vial, for intravenous use only. Distributed by Esteve Pharmaceuticals, S.A. The label includes dosage strength and usage instructions, along with a barcode and lot/expiration area.*
FDA Label Image

68118-200-10_box-1vial (68118 200 10 Box 1vial)

68118-200-10_box-1vial (68118 200 10 Box 1vial)
Label for Quzyttir Cetirizine HCl Injection 10 mg/mL, a 1 mL single-dose vial for intravenous use only. The label includes dosage strength, usage instructions, storage conditions, barcode, and distribution details from Esteve Pharmaceuticals, S.A., Barcelona, Spain. The design features the product name prominently in orange and black text with the Esteve logo.*
FDA Label Image

68118-200-25_box25 Vials (68118 200 25 Box 25vials)

68118-200-25_box25 Vials (68118 200 25 Box 25vials)
Packaging label for QUZYTTIR Cetirizine HCl Injection 10 mg/mL. The product is for intravenous use only and contains 1 mL single-dose vials in a carton of 25. Distributed by Esteve Pharmaceuticals, S.A., Barcelona, Spain. The label includes usage instructions and storage recommendations.*
FDA Label Image

Chemical Structure (Quz00 0000 01)

Chemical Structure (Quz00 0000 01)
Chemical structure of Cetirizine Hydrochloride, the active ingredient in QUZYTTIR 10 mg/mL injection. The structure includes a chlorophenyl group, a piperazine ring, and a carboxylic acid moiety with two hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.